SC 13G

Company

NewAmsterdam Pharma Co N.V.

Filed

June 20, 2023

Accession Number

0001140361-23-030497

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →